Binding of antidepressants to human brain receptors: focus on newer generation compounds

@article{Cusack2005BindingOA,
  title={Binding of antidepressants to human brain receptors: focus on newer generation compounds},
  author={Bernadette Cusack and Albert Nelson and Elliott Richelson},
  journal={Psychopharmacology},
  year={2005},
  volume={114},
  pages={559-565}
}
Using radioligand binding assays and postmortem normal human brain tissue, we obtained equilibrium dissociation constants (Kds) for 17 antidepressants and two of their metabolites at histamine H1, muscarinic, α1-adrenergic, α2-adrenergic, dopamine D2, serotonin 5-HT1A, and serotonin 5-HT2 receptors. Several newer antidepressants were compared with older drugs. In addition, we studied some antimuscarinic, antiparkinson, antihistamine, and neuroleptic compounds at some of these receptors. For the… 

Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test

TLDR
The results strongly suggest that activation of 5- HT2A receptors is critically involved in the anxiolytic activity of paroxetine, whereas the 5-HT2A and 5-ht2B receptors are involved inThe anti-punishment action of venlafaxine in the FPT.

In Vitro Pharmacology of Clinically Used Central Nervous System-Active Drugs as Inverse H1 Receptor Agonists

TLDR
A large number of varied clinical and chemical classes of drugs that are active in the central nervous system that display potent H1R inverse agonist activity are reported on.

Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy

TLDR
Evaluated cell membranes show that CBD interacts with human 5-HT1A receptors of the hippocampus and temporal neocortex, and at low concentrations, the effect of CBD upon Gi/o protein activation is limited, however, at high concentrations, CBD acts as an inverse agonist of 5- HT1A receptor.

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders.

TLDR
A thorough overview of the therapeutic potential of D2 R modulators in the treatment of schizophrenia, Parkinson's disease, depression, and anxiety is provided, with a focus on the dopaminergic pathway underlying these pathologies.

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography.

TLDR
The present status of the development of (11)C- or (18)F-labeled ligands as tools for imaging NET in brain with PET in support of neuropsychiatric clinical research and drug development is summarized.

Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism

TLDR
Trazodone, at concentrations relevant to its clinical effects, exerts weak partial agonism at 5-HT1AARs and disfacilitation of firing through α1-adrenoceptor antagonism, which converge in inhibiting dorsal raphe serotonergic neuron activity.

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors

TLDR
This study examined 101 clinical drugs and laboratory compounds to build a comprehensive understanding of α1‐adrenoceptor subtype affinity and selectivity and concluded that the addition of α blockers for the management of hypertension or BPH in people already taking tricyclic antidepressants and certain antipsychotics may not be beneficial.

Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan

TLDR
Data suggest that dextromethorphan exerts some of its antidepressant actions through σ1 receptors, which has been hypothesized to display rapid-acting antidepressant activity based on pharmacodynamic similarities to the N-methyl-D-aspartate receptor antagonist ketamine.

Antidepressant Treatment Reduces Serotonin-1A Autoreceptor Binding in Major Depressive Disorder

...

References

SHOWING 1-10 OF 26 REFERENCES

Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.

TLDR
At the human brain histamines H1 receptor, antidepressants remained among the most potent histamine H1 antagonists known, although their affinities for human receptors were lower than those for animal receptors.

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.

Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro.

Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.

TLDR
Clozapine's unusual efficacy in refractory schizophrenic patients and its low incidence of extrapyramidal side effects may be explained, but because most other atypical neuroleptics studied lacked high affinity and selectivity at muscarinic receptor subtypes, it is likely that other mechanisms are involved as well.

Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro.

Histamine H1 receptors in human brain labelled with [3H]Doxepin

Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT

TLDR
3H-PAT seems to be a useful ligand for studying the biochemical and pharmacological characteristics of presynaptic autoreceptors in selected regions of rat brain.